New joint venture aims to ‘open’ funding opportunities for early medicines discovery
Collaboration will drive medicines discovery in areas of unmet patient need
Read Moreby Lucy Parsons | Aug 11, 2021 | News | 0
Collaboration will drive medicines discovery in areas of unmet patient need
Read Moreby Lucy Parsons | Feb 22, 2021 | News | 0
Joint venture, MedX, will provide teleradiology reporting services
Read Moreby Selina McKee | Dec 19, 2018 | News | 0
GlaxoSmithKline and Pfizer have unveiled plans to combine their consumer health businesses into a new world-leading Joint Venture worth around £9.8 billion.
Read Moreby Selina McKee | Mar 27, 2018 | News | 0
GlaxoSmithKline is buying Novartis’ stake in the firms’ consumer healthcare unit, the announcement coming just days after the drug giant said it would not pursue acquisition of Pfizer’s consumer healthcare business.
Read Moreby Selina McKee | Nov 28, 2017 | News | 0
AstraZeneca has entered into a strategic joint venture with the Chinese Future Industry Investment Fund (FIIF) to form an equally-owned, stand-alone company in China.
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
